MARKER THERAPEUTICS INC MRKR
ASignal's systematic analysis rates MRKR as Bearish.
Reflects the latest available analysis · analyzed Nov 10, 2026
The case on MRKR
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- No debt (total_debt: $0)
- High liquidity with current_ratio: 6.03x
- Cash-rich balance sheet ($11.33M in cash)
- Negative RSI (38.76) indicating weak momentum
- Negative MACD histogram suggests bearish momentum
- Price below SMA20 and SMA50 indicating downtrend
- Negative gross, operating, and net margins
- Negative return on equity and return on assets
- Low news coverage from only one source (Yahoo)
See the full verdict on MRKR
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MRKR
Most investors never get a second opinion, let alone several. ASignal runs MRKR past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.